Holen Sie sich die Stockscreener-App
0.9559
3.25%
-0.0321
Handel nachbörslich:
.93
-0.0259
-2.71%
Calcimedica Inc Aktie (CALC) Neueste Nachrichten
CALCCalciMedica Inc Options - Finviz
CalciMedica (NASDAQ: CALC) gains 6.9% holder via June 2026 private placement - Stock Titan
Bering Partners II Discloses Investment at CalciMedica with 6.9% Stake - TradingView
Form 13D/A CALCIMEDICA For: 30 June By Investing.com - Investing.com Nigeria
CalciMedica (CALC) insiders add shares via open-market and unit purchases - Stock Titan
Form 4 CalciMedica Inc For: 29 June By Investing.com - Investing.com South Africa
Calcimedica director Fred Middleton acquires $199,999 in stock. - Investing.com
Calcimedica director Fred Middleton acquires $199,999 in stock. By Investing.com - Investing.com Australia
CalciMedica (CALC) Chief Medical Officer acquires 124,486 shares via board-approved deal - Stock Titan
CalciMedica (CALC) insider-affiliated fund buys 248,972 new shares at $0.8033 - Stock Titan
FDA raises no concerns over Auxora safety data, CalciMedica advances trial - MSN
CalciMedica (NASDAQ: CALC) lenders capped at 4.99% ownership after loan amendment - Stock Titan
Key facts: CalciMedica $15M raise; Auxora paused, FDA feedback due Q3 - TradingView
Analysts Offer Insights on Healthcare Companies: OnKure Therapeutics (OKUR) and CalciMedica (CALC) - The Globe and Mail
CalciMedica Receives FDA Clearance to Resume Auxora Clinical Trial for Acute Kidney Injury After Safety Review - Minichart
CalciMedica Announces Private Placement Financing for Up to About $49M to Advance Pulmonary Hypertension Program - Moomoo
CalciMedica Advances Auxora After Favorable FDA Safety Review - TipRanks
CalciMedica (Nasdaq: CALC) raises $15M, maps PAH and PH trial plans - Stock Titan
H.C. Wainwright Maintains CalciMedica(CALC.US) With Hold Rating - Moomoo
CalciMedica says FDA allows KOURAGE trial to continue - grafa.com
CalciMedica receives FDA clearance to continue Auxora trial By Investing.com - Investing.com Australia
CalciMedica, Inc. Announces Amendments to Loan and Warrant Agreements with Avenue Venture Opportunities Fund II, L.P – Minichart - Minichart
$CalciMedica (CALC.US)$ - Moomoo
What's Going On With CalciMedica Stock Wednesday?CalciMedica (NASDAQ:CALC) - Benzinga
CalciMedica secures up to $49M private placement financing - Investing.com
CalciMedica receives FDA clearance to continue Auxora trial - Investing.com
CalciMedica: Proceeds Expected to Support Pulmonary Hypertension Strategy, Including Phase 1b POC Study Evaluating Auxora in PAH, With Data Anticipated Mid-2027, and Advancement of Oral CRAC Channel Inhibitor CM5480 to IND Clearance Expecte - Moomoo
CalciMedica Says Auxora Phase 2 Trial May Continue Dosing After FDA Review - marketscreener.com
CalciMedica to Sell 18.7M Units >CALC - Moomoo
CalciMedica Announces Clinical Development of Auxora May Proceed Following FDA Review of KOURAGE Trial Interim Safety Data - The AI Journal
CalciMedica Entered Into Definitive Securities Purchase Agreement With Leading Healthcare Investors >CALC - Moomoo
CalciMedica Amends Loan, Issues New Equity Warrants - TipRanks
Calcimedica Announces Private Placement Financing For Up To Approximately $49 Million To Advance Pulmonary Hypertension Program - TradingView
Press Release: CalciMedica Announces Private Placement Financing for Up to Approximately $49 Million to Advance Pulmonary Hypertension Program - Moomoo
CalciMedica Extends $10M Loan, Adds $3M Conversion; Issues New $1.00 Warrants - TradingView
CalciMedica (NASDAQ: CALC) extends Avenue loan and issues new $1.00 warrants - Stock Titan
CALC News | CALCIMEDICA INC (NASDAQ:CALC) - ChartMill
CalciMedica Inc (CALC) Valuation: PE, PB & Fair Value Analysis - TradingKey
CalciMedica Inc (CALC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
CalciMedica Inc (CALC) Institutional Confidence - TradingKey
CalciMedica Inc (CALC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CalciMedica Inc (CALC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
CalciMedica Inc (CALC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
CalciMedica Inc (CALC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CalciMedica Inc (CALC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
CalciMedica (CALC) Holds Steady Above $0.83 Support After Nearly Flat SessionPercent Above MA - newsline.com
CalciMedica (CALC) Slips 2.75% as Stock Tests Key Support LevelsVolatility Breakout Picks - newsline.com
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
CALC Q1 2026 Earnings: Surprising Profitability Amid No RevenueHigh Growth Earnings - newsline.com
CALC Stock Chart | CALCIMEDICA INC (NASDAQ:CALC) - ChartMill
CALC Q1 2026 Earnings: Surprise Profit Amid Pre-Revenue Pipeline ProgressPost-Earnings Drift - newsline.com
CalciMedica (CALC) Slips 6%: Support Level Holds Key to RecoveryCTA Positioning - newsline.com
CalciMedica (CALC) Faces Selling Pressure Near Support as Biotech Uncertainty PersistsRevenue Weighted - newsline.com
CALC Q1 2026 Earnings: Surprising Profit on a Per‑Share Basis, Yet Shares DeclineOne-Time Loss Impact - thelegaladvocate.com
1.18%
2.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):